Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Post-traumatic Stress Disorder (PTSD) is a debilitating mental disorder that affects approximately 7% of the general population. This project's aim is to develop a greater understanding of the efficacy and underlying mechanisms of narrative exposure based treatments for PTSD. Adult participants (N=162) who meet DSM-5 criteria for PTSD will be enrolled in a 3-arm randomized clinical trial consisting of trauma-related expressive writing, trauma-related expressive speaking, or a factual expressive writing control condition. Treatments will be manualized and conducted entirely through the Qualtrics survey platform. Treatment will consist of six sessions, three per week over two weeks, taking place via the internet. Assessments will be conducted pre-treatment, post-treatment, and at 1-month follow-up in the lab. Assessments will be comprised of symptom self-report measures as well as two tasks completed in an eye tracker: a reading task to evaluate mechanisms underlying trauma narrative processing and a sentence production task to evaluate attentional shifts when producing verbal information
Specific Aims and Hypotheses:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Trauma Related Expressive Writing | Active Comparator | Participants randomized to this condition will complete six sessions during which they will write about their trauma for 20 minutes. The participant will receive instructions to write about the traumatic event that they feel affects them the most. For each session they will be instructed to write about the same event. For the first session, participants will complete psychoeducation and treatment rationale modules. The instructions for writing about the traumatic event will emphasize the importance of exploring their deepest emotions and thoughts at the time of the event, as well as providing detailed information about the event itself. For the remaining five writing sessions participants will be instructed to write about the same event and to focus on providing a detailed description of the part of the event that was most distressing to them, as well as how the event had affected their lives. A researcher will review the writing independently to ensure treatment compliance. |
|
| Neutral Expressive Writing | Sham Comparator | Participants randomized to this condition will complete six sessions during which they will write about their day, without describing emotions or opinions. Previous research has shown a significant reduction of symptoms with this type of control writing condition in participants with PTSD (Sloan et al., 2011). A researcher will review the writing to ensure compliance. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Trauma Related Expressive Writing | Behavioral | Participants will write about the traumatic event over the course of six sessions. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in PTSD symptom severity | PTSD Symptom Checklist at each assessment | Pre-treatment (baseline), Post-treatment (2-weeks), Follow-up (1 month, 3 months, 6 months) |
| Change in Depression symptoms | Becks Depression Inventory at each assessment | Pre-treatment (baseline), Post-treatment (2-weeks), Follow-up (1 month) |
| Change in Posttraumatic Growth | Post Traumatic Growth Inventory at each assessment | Pre-treatment (baseline), Post-treatment (2-weeks), Follow-up (1 month) |
| Change in Reading Task indices | Reading narratives in an eye tracker at each assessment | Pre-treatment (baseline), Post-treatment (2-weeks), Follow-up (1 month) |
| Change in Sentence Production Task indices | Describing images in an eye tracker at each assessment | Pre-treatment (baseline), Post-treatment (2-weeks), Follow-up (1 month) |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Michael Telch, PhD | Contact | (512)-560-4100 | telch@austin.utexas.edu | |
| Mikael Rubin, MA | Contact | 6466854681 | mikaelrubin@utexas.edu |
| Name | Affiliation | Role |
|---|---|---|
| Michael Telch, Phd | University of Texas at Austin | Principal Investigator |
| Mikael Rubin, MA | University of Texas at Austin | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Laboratory for the Study of Anxiety Disorders | Recruiting | Austin | Texas | 78712 | United States |
Not provided
| Label | URL |
|---|---|
| Description Website for the Laboratory for the Study of Anxiety Disorders | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D013313 | Stress Disorders, Post-Traumatic |
| ID | Term |
|---|---|
| D040921 | Stress Disorders, Traumatic |
| D000068099 | Trauma and Stressor Related Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Neutral Expressive Writing | Behavioral | Participants will write about a neutral event over the course of six sessions. |
|